Sansure Biotech Inc
SSE:688289
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sansure Biotech Inc
SSE:688289
|
CN |
|
M
|
Media Matrix Worldwide Ltd
BSE:512267
|
IN |
|
ERI Holdings Co Ltd
TSE:6083
|
JP |
|
A
|
Arion banki hf
ICEX:ARION
|
IS |
|
X
|
XMReality AB (publ)
STO:XMR
|
SE |
|
K
|
KBC Corporation Ltd
SSE:688598
|
CN |
|
Asiatic Group (Holdings) Ltd
SGX:5CR
|
SG |
|
ValueCommerce Co Ltd
TSE:2491
|
JP |
|
Atomo Diagnostics Ltd
ASX:AT1
|
AU |
|
C
|
Compugates Holdings Bhd
KLSE:COMPUGT
|
MY |
|
U
|
U Power Ltd
NASDAQ:UCAR
|
CN |
|
A
|
Astra Graphia Tbk PT
IDX:ASGR
|
ID |
Wall Street
Price Targets
Price Targets Summary
Sansure Biotech Inc
According to Wall Street analysts, the average 1-year price target for Sansure Biotech Inc is 22.46 CNY with a low forecast of 22.24 CNY and a high forecast of 23.12 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Sansure Biotech Inc's stock price target?
Price Target
22.46
CNY
According to Wall Street analysts, the average 1-year price target for Sansure Biotech Inc is 22.46 CNY with a low forecast of 22.24 CNY and a high forecast of 23.12 CNY.
What is Sansure Biotech Inc's Revenue forecast?
Projected CAGR
21%
For the last 6 years the compound annual growth rate for Sansure Biotech Inc's revenue is 30%. The projected CAGR for the next 3 years is 21%.
What is Sansure Biotech Inc's Operating Income forecast?
Projected CAGR
85%
For the last 6 years the compound annual growth rate for Sansure Biotech Inc's operating income is 70%. The projected CAGR for the next 1 year is 85%.
What is Sansure Biotech Inc's Net Income forecast?
Projected CAGR
16%
For the last 6 years the compound annual growth rate for Sansure Biotech Inc's net income is 85%. The projected CAGR for the next 3 years is 16%.
